Last Chance Pe/cyanine7 Anti-human Cd261 (dr4, Trail-r1) Now 40% Cheaper [jan78vgD]

Highly Specific PE/Cyanine7 Anti-Human CD261 (DR4, TRAIL-R1) Antibody

The Last Chance Pe/cyanine7 Anti-human Cd261 (dr4, Trail-r1) Now 40% Cheaper [jan78vgD] antibody is a powerful tool for researchers studying the TNFR superfamily, particularly the 56 kD member 10A, also known as TRAIL-R1, Apo-2, and CD261. This monoclonal antibody, clone DJR1, is designed to specifically target and bind to human DR4, making it an ideal choice for various immunoassay applications.

Key Features and Specifications

• Clone: DJR1
• Antibody Type: Monoclonal
• Reactivity: Human
• Format: PE-Cyanine7
• Host: Mouse
• Isotype: IgG1, κ
• Applications: Flow Cytometry - Quality tested
• Regulatory Status: RUO (Research Use Only)

This antibody offers exceptional specificity and sensitivity, making it a valuable asset in your research toolkit. The PE-Cyanine7 conjugation provides bright fluorescence, enhancing the visibility of your samples in flow cytometry assays.

Practical Applications and Benefits

The Last Chance Pe/cyanine7 Anti-human Cd261 (dr4, Trail-r1) Now 40% Cheaper [jan78vgD] antibody is highly suitable for a variety of research applications, including flow cytometry. Its ability to detect and bind to DR4 on activated T cells and certain tumors makes it particularly useful in studies involving apoptosis and TRAIL engagement. By using this antibody, researchers can gain valuable insights into the role of DR4 in immune responses and tumor progression. The high-quality formulation and validated applications ensure reliable results, enhancing the efficiency of your experiments.